Page last updated: 2024-08-22

molybdenum and trientine

molybdenum has been researched along with trientine in 25 studies

Research

Studies (25)

TimeframeStudies, this research(%)All Research%
pre-19901 (4.00)18.7374
1990's4 (16.00)18.2507
2000's12 (48.00)29.6817
2010's8 (32.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cramarossa, L; D'Angelo, D; D'Ascanio, I; Ferri, GB; Piane, E1
Mason, J; McQuaid, A1
Brewer, GJ; Yuzbasiyan-Gurkan, V1
Brewer, GJ4
Schilsky, ML2
Bronstein, JM; Subramanian, I; Vanek, ZF1
Pérez-Aguilar, F1
Brechbiel, M; Camphausen, K; Sproull, M1
El-Youssef, M1
Szalay, F1
Askari, F; Brewer, GJ; Carlson, M; Dick, RB; Fink, JK; Hedera, P; Kluin, KJ; Lorincz, MT; Moretti, P; Schilsky, M; Sitterly, J; Tankanow, R1
Medici, V; Rossaro, L; Sturniolo, GC1
Askari, F; Brewer, GJ; Carlson, M; Dick, RB; Fink, JK; Kluin, KJ; Lorincz, MT; Sitterly, J1
Askari, F; Brewer, GJ; Burke, JF; Dayalu, P; Lorincz, MT; Nan, B1
Purchase, R1
Brůha, R; Mareček, Z1
Stremmel, W; Weiss, KH1
Chen, C; Li, WJ; Wang, XP; Yang, RM; You, ZF1
Alhonen, L; Hyvönen, MT; Keinänen, TA; Khomutov, AR; Khomutov, M; Pasanen, M; Peräniemi, S; Ucal, S; Vepsäläinen, J; Weisell, J1
Członkowska, A; Litwin, T1
Appenzeller-Herzog, C; Ewald, H; Heeres, MLS; Houwen, RHJ; Mathes, T; Weiss, KH1

Reviews

20 review(s) available for molybdenum and trientine

ArticleYear
[Wilson's disease].
    Recenti progressi in medicina, 1992, Volume: 83, Issue:5

    Topics: Acetates; Acetic Acid; Adult; Diagnosis, Differential; Diet; Female; Hepatolenticular Degeneration; Humans; Male; Molybdenum; Penicillamine; Pyridoxine; Sulfates; Trientine; Zinc; Zinc Sulfate

1992
Wilson's disease: an update, with emphasis on new approaches to treatment.
    Digestive diseases (Basel, Switzerland), 1989, Volume: 7, Issue:4

    Topics: Copper; Female; Hepatolenticular Degeneration; Humans; Molybdenum; Penicillamine; Pregnancy; Trientine; Zinc

1989
Practical recommendations and new therapies for Wilson's disease.
    Drugs, 1995, Volume: 50, Issue:2

    Topics: Chelating Agents; Copper; Female; Hepatolenticular Degeneration; Humans; Liver; Metallothionein; Molybdenum; Penicillamine; Pregnancy; Trientine; Zinc

1995
Wilson disease: genetic basis of copper toxicity and natural history.
    Seminars in liver disease, 1996, Volume: 16, Issue:1

    Topics: Adenosine Triphosphatases; Carrier Proteins; Cation Transport Proteins; Chelating Agents; Chelation Therapy; Chromosome Mapping; Copper; Copper-Transporting ATPases; Environment; Genetic Therapy; Genome, Human; Hepatitis; Hepatolenticular Degeneration; Humans; Liver Transplantation; Molybdenum; Mutation; Penicillamine; Risk Factors; Trientine; Zinc

1996
Treatment of Wilson's disease: what are the relative roles of penicillamine, trientine, and zinc supplementation?
    Current gastroenterology reports, 2001, Volume: 3, Issue:1

    Topics: Adenosine Triphosphatases; Chelating Agents; Drug Therapy, Combination; Female; Hepatolenticular Degeneration; Humans; Molybdenum; Penicillamine; Pregnancy; Trientine; Zinc

2001
Diagnosis and treatment of Wilson's disease.
    Current neurology and neuroscience reports, 2002, Volume: 2, Issue:4

    Topics: Chelating Agents; Copper; Dimercaprol; Enzyme Inhibitors; Female; Hepatolenticular Degeneration; Humans; Liver Transplantation; Male; Molybdenum; Penicillamine; Trientine; Zinc

2002
[Wilson's disease: physiopathological, clinical and therapeutic considerations].
    Gastroenterologia y hepatologia, 2003, Volume: 26, Issue:1

    Topics: Adenosine Triphosphatases; Adolescent; Adult; Basal Ganglia Diseases; Brain; Cation Transport Proteins; Ceruloplasmin; Chelating Agents; Chelation Therapy; Copper; Copper-Transporting ATPases; Descemet Membrane; Female; Genes, Recessive; Hepatitis, Chronic; Hepatolenticular Degeneration; Humans; Liver Transplantation; Male; Mental Disorders; Middle Aged; Molybdenum; Penicillamine; Pregnancy; Pregnancy Complications; Prognosis; Recombinant Fusion Proteins; Trientine; Zinc

2003
Antiangiogenic therapy through copper chelation.
    Expert opinion on therapeutic targets, 2003, Volume: 7, Issue:3

    Topics: Angiogenesis Inhibitors; Animals; Chelating Agents; Chelation Therapy; Copper; Corneal Neovascularization; Cyclohexylamines; Hepatolenticular Degeneration; Humans; Molybdenum; Neoplasms; Neovascularization, Pathologic; Penicillamine; Pyridines; Rabbits; Trientine

2003
Wilson disease.
    Mayo Clinic proceedings, 2003, Volume: 78, Issue:9

    Topics: Adenosine Triphosphatases; Chelating Agents; Copper; Hepatolenticular Degeneration; Humans; Liver Transplantation; Molybdenum; Penicillamine; Trientine; Zinc

2003
[Wilson disease in 2003].
    Orvosi hetilap, 2003, Dec-14, Volume: 144, Issue:50

    Topics: Adenosine Triphosphatases; Cation Transport Proteins; Chelating Agents; Copper; Copper-Transporting ATPases; Diagnosis, Differential; Family Planning Services; Genetic Counseling; Genotype; Hepatolenticular Degeneration; Humans; Molybdenum; Penicillamine; Phenotype; Trientine; Zinc Acetate; Zinc Sulfate

2003
Neurologically presenting Wilson's disease: epidemiology, pathophysiology and treatment.
    CNS drugs, 2005, Volume: 19, Issue:3

    Topics: Behavior; Chelating Agents; Enzyme Inhibitors; Hepatolenticular Degeneration; Humans; Molybdenum; Nervous System Diseases; Penicillamine; Trientine; Zinc

2005
Anticopper therapy against cancer and diseases of inflammation and fibrosis.
    Drug discovery today, 2005, Aug-15, Volume: 10, Issue:16

    Topics: Animals; Copper; Fibrosis; Humans; Inflammation; Molybdenum; Neoplasms; Neovascularization, Pathologic; Penicillamine; Trientine

2005
Wilson disease--a practical approach to diagnosis, treatment and follow-up.
    Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2007, Volume: 39, Issue:7

    Topics: Ceruloplasmin; Chelating Agents; Copper; Hepatolenticular Degeneration; Humans; Liver Transplantation; Molybdenum; Mutation; Penicillamine; Trace Elements; Treatment Outcome; Trientine; Zinc

2007
The risks of free copper in the body and the development of useful anticopper drugs.
    Current opinion in clinical nutrition and metabolic care, 2008, Volume: 11, Issue:6

    Topics: Alzheimer Disease; Angiogenesis Inhibitors; Autoimmunity; Copper; Fibrosis; Hepatolenticular Degeneration; Humans; Inflammation; Molybdenum; Neurodegenerative Diseases; Penicillamine; Trientine

2008
The treatment of Wilson's disease, a rare genetic disorder of copper metabolism.
    Science progress, 2013, Volume: 96, Issue:Pt 1

    Topics: Brain; Chelating Agents; Copper; Cornea; Dimercaprol; Drug Discovery; Hepatolenticular Degeneration; History, 20th Century; Humans; Liver; Molybdenum; Penicillamine; Rare Diseases; Trientine; Zinc Sulfate

2013
[Wilsons disease].
    Vnitrni lekarstvi, 2013, Volume: 59, Issue:7

    Topics: Adenosine Triphosphatases; Adult; Cation Transport Proteins; Chelating Agents; Copper; Copper-Transporting ATPases; Czech Republic; Female; Hepatolenticular Degeneration; Humans; Liver Cirrhosis; Liver Transplantation; Male; Molybdenum; Mutation; Penicillamine; Trientine; Zinc

2013
Clinical considerations for an effective medical therapy in Wilson's disease.
    Annals of the New York Academy of Sciences, 2014, Volume: 1315

    Topics: Ceruloplasmin; Chelating Agents; Copper; Hepatolenticular Degeneration; Humans; Molybdenum; Penicillamine; Trientine; Zinc

2014
Current Drug Managements of Wilson's Disease: From West to East.
    Current neuropharmacology, 2016, Volume: 14, Issue:4

    Topics: Chelating Agents; Copper; Hepatolenticular Degeneration; Humans; Medicine, Chinese Traditional; Molybdenum; Penicillamine; Succimer; Treatment Outcome; Trientine; Zinc

2016
Wilson disease - currently used anticopper therapy.
    Handbook of clinical neurology, 2017, Volume: 142

    Topics: Chelating Agents; Copper; Enzyme Inhibitors; Hepatolenticular Degeneration; Humans; Molybdenum; Penicillamine; Prospective Studies; Trientine

2017
Comparative effectiveness of common therapies for Wilson disease: A systematic review and meta-analysis of controlled studies.
    Liver international : official journal of the International Association for the Study of the Liver, 2019, Volume: 39, Issue:11

    Topics: Chelating Agents; Copper; Hepatolenticular Degeneration; Humans; Liver; Molybdenum; Penicillamine; Randomized Controlled Trials as Topic; Trientine; Zinc

2019

Trials

1 trial(s) available for molybdenum and trientine

ArticleYear
Treatment of Wilson disease with ammonium tetrathiomolybdate: IV. Comparison of tetrathiomolybdate and trientine in a double-blind study of treatment of the neurologic presentation of Wilson disease.
    Archives of neurology, 2006, Volume: 63, Issue:4

    Topics: Adolescent; Adult; Anemia; Chelating Agents; Copper; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Hepatolenticular Degeneration; Humans; Length of Stay; Male; Middle Aged; Molybdenum; Serum Albumin; Speech; Speech Disorders; Treatment Outcome; Trientine; Zinc

2006

Other Studies

4 other study(ies) available for molybdenum and trientine

ArticleYear
A comparison of the effects of penicillamine, trientine, and trithiomolybdate on [35S]-labeled metallothionein in vitro; implications for Wilson's disease therapy.
    Journal of inorganic biochemistry, 1991, Feb-01, Volume: 41, Issue:2

    Topics: Animals; Copper; Cytosol; Hepatolenticular Degeneration; Liver; Male; Metallothionein; Molybdenum; Penicillamine; Rats; Rats, Inbred Strains; Sulfur Radioisotopes; Trientine

1991
Treatment of Wilson's disease with tetrathiomolybdate: V. Control of free copper by tetrathiomolybdate and a comparison with trientine.
    Translational research : the journal of laboratory and clinical medicine, 2009, Volume: 154, Issue:2

    Topics: Chelating Agents; Clinical Trials as Topic; Copper; Double-Blind Method; Drug Administration Schedule; Hepatolenticular Degeneration; Humans; Molybdenum; Retrospective Studies; Trientine

2009
Prognostic significance of neurologic examination findings in Wilson disease.
    Parkinsonism & related disorders, 2011, Volume: 17, Issue:7

    Topics: Adult; Chelating Agents; Dystonia; Female; Hepatolenticular Degeneration; Humans; Male; Molybdenum; Neurologic Examination; Prognosis; Risk Factors; Tremor; Trientine; Zinc

2011
Triethylenetetramine modulates polyamine and energy metabolism and inhibits cancer cell proliferation.
    The Biochemical journal, 2016, 05-15, Volume: 473, Issue:10

    Topics: Amine Oxidase (Copper-Containing); Cell Line, Tumor; Cell Proliferation; Eflornithine; Energy Metabolism; Female; Humans; Male; MCF-7 Cells; Molybdenum; Penicillamine; Polyamines; Putrescine; Reactive Oxygen Species; Spermine; Trientine

2016